Last updated: August 16, 2026

Examiner: HOLTZMAN, KATHERINE ANN

Tech Center 1600 • Art Units: 1644 1646

This examiner grants 68% of resolved cases

Performance Statistics

67.6%

Allow Rate

+7.6% vs TC avg

Total Applications

+55.9%

Interview Lift

1330

Avg Prosecution Days

Based on 68 resolved cases, 2023–2026

5.6%

§101 Eligibility

12.4%

§102 Novelty

27.4%

§103 Obviousness

30.8%

§112 Clarity

App #	Title	Status	Assignee
17932739	TREATMENT OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA	Non-Final OA	AMGEN RESEARCH (MUNICH) GMBH
18465854	COMPOSITIONS AND METHODS OF TREATING LUPUS NEPHRITIS	Non-Final OA	Hoffmann-La Roche Inc.
17921600	COMPOSITIONS AND METHODS FOR TREATING INFLAMMASOME RELATED DISEASES OR CONDITIONS	Non-Final OA	University of Miami
17812058	METHOD FOR DETECTING INFLAMMASOME PROTEINS AS BIOMARKERS OF NEUROLOGICAL DISORDERS	Non-Final OA	University of Miami

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.